| |
| |
|
| Insider
Information: |
Behrens M Kathleen |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
371,047 |
|
|
Indirect Shares
|
400,313 |
|
|
| Direct
Value |
$29,201,632 |
|
|
|
Indirect Value
|
$1,580,600 |
|
|
| Total
Shares |
771,360 |
|
|
| Total
Value |
$30,782,232 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sarepta Therapeutics Inc |
SRPT |
|
2024-03-01 |
176,839 |
2024-03-01 |
10,000 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
|
|
Igm Biosciences, Inc. |
IGMS |
|
2024-03-29 |
10,046 |
2024-03-29 |
390,313 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
Director |
2024-06-05 |
184,162 |
2020-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2023-06-26 |
4 |
B |
$8.00 |
$900,000 |
I/I |
112,500 |
330,700 |
2.1 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2011-04-06 |
4 |
B |
$1.50 |
$150,000 |
D/D |
100,000 |
105,000 |
2.39 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2016-03-14 |
4 |
B |
$16.54 |
$1,075,276 |
D/D |
65,000 |
112,166 |
2.39 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-09-18 |
4 |
B |
$16.00 |
$1,000,000 |
D/D |
62,500 |
62,500 |
2.39 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-04-01 |
4 |
B |
$23.00 |
$1,399,987 |
I/I |
60,869 |
29,806 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2022-11-08 |
4 |
B |
$17.14 |
$1,028,550 |
I/I |
60,000 |
218,200 |
2.1 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2020-12-11 |
4 |
B |
$90.00 |
$3,999,960 |
I/I |
44,444 |
21,111 |
2.1 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2022-06-07 |
4 |
A |
$3.96 |
$174,996 |
D/D |
44,191 |
125,618 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
38,135 |
38,135 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2023-06-13 |
4 |
A |
$4.95 |
$175,002 |
D/D |
35,354 |
160,972 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2020-09-10 |
4 |
B |
$56.41 |
$1,823,408 |
D/D |
30,000 |
93,214 |
2.39 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2020-10-02 |
4 |
A |
$6.67 |
$174,994 |
D/D |
26,236 |
64,371 |
0 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2024-06-05 |
4 |
A |
$7.26 |
$168,359 |
D/D |
23,190 |
184,162 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Director |
– • – |
2019-12-09 |
4 |
B |
$24.26 |
$497,316 |
I/I |
20,000 |
10,000 |
2.1 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2022-12-19 |
4 |
OE |
$34.92 |
$698,400 |
D/D |
20,000 |
158,470 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2012-09-07 |
4 |
B |
$14.58 |
$257,724 |
D/D |
17,500 |
36,666 |
2.39 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2021-05-27 |
4 |
A |
$10.26 |
$174,995 |
D/D |
17,056 |
81,427 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2023-11-03 |
4 |
OE |
$29.03 |
$435,450 |
D/D |
15,000 |
174,993 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2016-03-16 |
4 |
B |
$14.54 |
$145,433 |
I/I |
10,000 |
21,855 |
2.1 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2018-10-31 |
4 |
S |
$131.71 |
$1,317,100 |
D/D |
(10,000) |
116,534 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2018-10-31 |
4 |
OE |
$3.96 |
$39,600 |
D/D |
10,000 |
126,534 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2013-09-16 |
4 |
B |
$37.04 |
$240,778 |
D/D |
6,500 |
44,166 |
2.39 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Director |
– • – |
2012-08-08 |
4 |
D |
$31.00 |
$186,000 |
D/D |
(6,000) |
0 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2011-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
110,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
